Erythroleukemia

• CLINICAL_TRIALS trial_result · 2025-04-29
  Clinical Trial Update: Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [EARLY_Phase 1]

  A Phase 1 trial evaluating a combination of sirolimus, idarubicin, and cytarabine in adults with newly diagnosed acute myeloid leukemia has …

• CLINICAL_TRIALS trial_result · 2025-04-02
  Clinical Trial Update: Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders [Phase 1]

  Phase 1 study of Veliparib with Topotecan, with or without Carboplatin, in relapsed or refractory acute leukemias, high-risk myelodysplastic…

• CLINICAL_TRIALS trial_result · 2017-12-06
  Clinical Trial Update: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

  A Phase 1 trial evaluating a MEK inhibitor (MEK162) in combination with idarubicin and cytarabine for adults with relapsed or refractory acu…

• CLINICAL_TRIALS trial_result · 2017-03-10
  Clinical Trial Update: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

  Phase 2 clinical trial update of ixazomib in relapsed or refractory acute myeloid leukemia has been terminated; results were posted previous…

• CLINICAL_TRIALS research · 2016-05-19
  Clinical Trial Update: Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia

  A completed pediatric AML biomarker study update from the Children's Oncology Group examining biomarkers in bone marrow from high-risk AML p…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-01-07
  Clinical Trial Update: AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

  Phase 2 trial evaluating AKT inhibitor MK-2206 in relapsed or refractory adult acute leukemias completed; results posted in 2015.

• CLINICAL_TRIALS trial_result · 2013-09-19
  Clinical Trial Update: Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]

  A Phase 1 trial evaluating the combination of entinostat and sorafenib in patients with advanced or metastatic solid tumors or relapsed/refr…

• CLINICAL_TRIALS trial_result · 2013-06-04
  Clinical Trial Update: Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 3]

  Phase 3 trial evaluating whether adding the P-glycoprotein modulator valspodar to standard chemotherapy improves outcomes in adults with pre…

• CLINICAL_TRIALS trial_result · 2013-02-08
  Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]

  Phase 1 trial update reporting initial safety and tolerability findings for XK469R in patients with refractory hematologic cancers.

• CLINICAL_TRIALS trial_result · 2013-01-24
  Clinical Trial Update: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

  Phase 2 trial of idarubicin and cytarabine with or without bevacizumab for newly diagnosed acute myeloid leukemia was terminated.